MedTrace Logo

Impact of Dexamethasone on the Duration of Sensory and Motor Block Following Spinal Anesthesia

NCT03078062 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-10-27

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of a single-dose of intravenous dexamethasone 8 mg on the duration of sensory and motor blockade following spinal anesthesia with isobaric bupivacaine.

The hypothesis of the study is that intravenous dexamethasone will significantly prolong (by more than 20 minutes) the duration of spinal anesthesia.

Conditions

  • Spinal Anesthesia
  • Prolonged Sensory Block
  • Prolonged Motor Block

Interventions

DRUG

Dexamethasone

Administration of a single-dose of intravenous dexamethasone 8 mg during spinal anesthesia

DRUG

Normal saline

Administration of a single-dose of Normal saline during spinal anesthesia

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Stephan R Williams, Md, PhD · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-26
Primary Completion
2017-10-26
Completion
2017-10-26

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078062 on ClinicalTrials.gov